Loading clinical trials...
Loading clinical trials...
A Single-arm, Open-lable, Multicenter, Phase II Clinical Study of LP002 in Combination With Chemotherapy for Patients With Extensive Stage Small Cell Lung Cancer
Conditions
Interventions
LP002
Carboplatin
+1 more
Locations
8
China
Henan Cancer Hospital
Zhengzhou, Henan, China
Hunan Cancer Hospital
Changsha, Hunan, China
Affiliated Hospital Of Jiangnan University
Wuxi, Jiangsu, China
The First Affiliated Hospital of Jinzhou Medical University
Jinzhou, Liaoning, China
Shandong Cancer Hospital
Jinan, Shandong, China
Fudan University Shanghai Cancer Center
Shanghai, Shanghai Municipality, China
Start Date
December 2, 2020
Primary Completion Date
February 1, 2022
Completion Date
August 1, 2022
Last Updated
February 5, 2021
NCT07336732
NCT06712355
NCT05419076
NCT06242470
NCT07161388
NCT07189455
Lead Sponsor
Taizhou HoudeAoke Biomedical Co., Ltd.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions